Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma. Academic Article uri icon

Overview

publication date

  • January 1, 1976

Research

keywords

  • BCG Vaccine
  • Melanoma

Identity

Scopus Document Identifier

  • 0017103627

Digital Object Identifier (DOI)

  • 10.1111/j.1749-6632.1976.tb41697.x

PubMed ID

  • 1069548

Additional Document Info

volume

  • 277

issue

  • 00